U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT07555171) titled 'EEG Dynamics in Lennox-Gastaut Syndrome Patients Undergoing Fenfluramine Treatment' on April 21.
Brief Summary: This study plans to learn if certain markers found during electroencephalogram (EEG) analysis could predict fenfluramine responsiveness to give clinicians greater insight into the effectiveness of fenfluramine in people with Lennox Gastaut Syndrome (LGS).
Study Start Date: April, 2026
Study Type: OBSERVATIONAL
Condition:
Lennox Gastaut Syndrome (LGS)
Intervention:
DRUG: fenfluramine HCl
Patients who receive fenfluramine will be enrolled in this non-interventional study.
Recruitment Status: ENROLLING_BY_INVITATION...